Alisa Vespa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alisa Vespa has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Aisar Atrakchi
US Food and Drug Administration/Center for Drug Evaluation and Research , Silver Spring, MD 20993
1 shared publication- Andreas Czich
Sanofi, R&D Translational Medicine Preclinical Safety , Frankfurt D-69526
1 shared publication - Anthony M. Lynch
Non-Clinical Safety, GSK R&D Stevenage, Stevenage, UK.
1 shared publication - Connie L. Chen
Health and Environmental Sciences Institute Washington DC USA
1 shared publication Gabriela De Oliveira Silveira
Lhasa Limited , Leeds , Canal Wharf, Leeds LS11 5PS
1 shared publicationJennifer Cheung
Pfizer Research, Development, and Medical , Groton, CT 06370
1 shared publication
Latest Publications
- Open Access
- 14 February 2026
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 41 (4) , 225-236
Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop
Detection of N-nitrosamines (NA) in pharmaceuticals became a point of interest due to the mutagenic and carcinogenic potential of some compounds of this class, and their identification as nitrosated forms of marketed drugs, otherwise known as NA Drug Substance-Related Impurities (NDSRIs). The Ames test is used to assess the mutagenic potential of drug impurities, including NAs. Concerns over the sensitivity of the Ames test, as recommended in Organization for Economic Co-operation and Development Test Guideline 471, in predicting the rodent carcinogenic potential of NAs has prompted optimization of several test parameters used for detecting the mutagenicity of NAs (e.g. methods used for metabolic activation and the selection of tester strains). In order to discuss optimal Ames test conditions for the evaluation of NAs, including NDSRIs, the Office of New Drugs in the US Food and Drug Administration’s Center for Drug Evaluation and Research and the Health and Environmental Sciences Institute’s Genetic Toxicology Technical Committee co-organized and co-sponsored a workshop entitled “Nitrosamines: Ames Data Review and Method Development Workshop”. The workshop featured five sessions addressing charge questions pertinent to the Ames test conditions and performance through the presentation of data and panel discussions. This report outlines the key takeaway points from the workshop.
- 14 February 2026
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 41 (4) , 225-236
Open AccessNitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop
Detection of N-nitrosamines (NA) in pharmaceuticals became a point of interest due to the mutagenic and carcinogenic potential of some compounds of this class, and their identification as nitrosated forms of marketed drugs, otherwise known as NA Drug Substance-Related Impurities (NDSRIs). The Ames test is used to assess the mutagenic potential of drug impurities, including NAs. Concerns over the sensitivity of the Ames test, as recommended in Organization for Economic Co-operation and Development Test Guideline 471, in predicting the rodent carcinogenic potential of NAs has prompted optimization of several test parameters used for detecting the mutagenicity of NAs (e.g. methods used for metabolic activation and the selection of tester strains). In order to discuss optimal Ames test conditions for the evaluation of NAs, including NDSRIs, the Office of New Drugs in the US Food and Drug Administration’s Center for Drug Evaluation and Research and the Health and Environmental Sciences Institute’s Genetic Toxicology Technical Committee co-organized and co-sponsored a workshop entitled “Nitrosamines: Ames Data Review and Method Development Workshop”. The workshop featured five sessions addressing charge questions pertinent to the Ames test conditions and performance through the presentation of data and panel discussions. This report outlines the key takeaway points from the workshop.